对死后肺部的基因调控网络分析揭示了对COVID-19病原体的新见解
Ryan Bloomquist1,2, Ashis K Mondal1, Ashutosh Vashisht1
1Department of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30909, USA.
这项研究分析了COVID-19死者和对照个体的肺组织,揭示了微RNA (miRNA) 和信使RNA (mRNA) 表达的显著变化. 这些发现突出显示了COVID-19肺组织中免疫反应的改变.
科学领域:
- * 分子生物学 * 分子生物学
- * 免疫学 免疫学
- * 病毒学 病毒学
背景情况:
- * 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 流行病突显了了解肺组织中宿主反应的必要性.
- * 有限的数据存在于严重的冠状病毒疾病2019 (COVID-19) 期间人类肺部内的特定免疫反应.
研究的目的:
- *与对照组相比,研究COVID-19死亡个体的肺组织中微RNA (miRNA) 和信使RNA (mRNA) 的差异表达.
- * 阐明参与肺内COVID-19病变发生的宿主细胞和免疫机制.
主要方法:
- *分析了5名COVID-19死者和7名对照个体的肺活检样本中的miRNA和mRNA表达.
- *利用miRNA微阵列和Nanostring的nCounter XT基因表达试验进行宿主反应基因表达分析.
- * 采用分层聚类,PCA K-means,以及丰富/网络分析来解释基因表达数据.
主要成果:
- * 在COVID-19肺样本中确定了37个下调和77个上调的miRNA.
- *观察到653个mRNA转录的差异表达,其中472个在COVID-19标本中下调.
- *对COVID-19和对照样本进行了明确的分类,富化分析显示了干扰素信号的上调和互白素-17信号通路的下调.
结论:
- *miRNA和mRNA表达模式的显著变化是COVID-19肺组织的特征.
- *这项研究揭示了干扰素和互白素-17信号在肺部对SARS-CoV-2感染宿主反应中的关键作用.
- *研究结果提供了对COVID-19病原体的洞察,并建议潜在的治疗点,用于预防和治疗感染.
更多相关视频
10:12Establishing Human Lung Organoids and Proximal Differentiation to Generate Mature Airway Organoids
Published on: March 23, 2022
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
相关概念视频
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Respiratory Syncytial Virus Disease
